The proposed MGMT-STP27 MGMT classification model will allow investigation of distinct epigenetic features associated with MGMT silencing in the context of CIMP-positive or CIMP-negative gliomas by multidimensional analysis of respective molecular and clinical data. This evidence concerns the gene MGMT and glioma.